All The Sex Issue articles
-
NewsHPV vaccination uptake in adults shaped by knowledge and medical advice
A nationwide survey of HPV uptake in Switzerland found just over 27% of the approximately 3,850 adults aged 18 to 45 surveyed had received at least one dose of the vaccine. While nearly 59% of those aged 18 to 26 are vaccinated, the rate drops to around 16% among those aged 27 to 45.
-
NewsHow periodontitis-linked bacteria accelerate osteoporosis-like bone loss through the gut
Researchers reveal that salivary bacteria from gum disease alter gut metabolism, driving osteoclast activity and systemic bone loss. They analyzed salivary microbiota from individuals with advanced periodontitis and compared them with samples from periodontally healthy donors.
-
NewsTestosterone increases severity of bacterial skin infections
Men are more susceptible than women to skin infections caused by Staphylococcus aureus bacteria, but the biological basis for this disparity has remained unclear. A new study is the first to reveal testosterone, present at higher levels in males, as a key driver of infection.
-
NewsFecal transplants from older mice significantly improve ovarian function and fertility in younger mice
A new study details how fecal transplants from older female mice significantly improve ovarian function and fertility in young mice. The surprising results reveal a direct link between the microbiome of the gut and ovarian health and function.
-
NewsAkkermansia muciniphila PROBIO therapy promotes arginine biosynthesis and reverses reproductive impairments in polycystic ovary syndrome rats
A research study investigated the therapeutic potential of Akkermansia muciniphila PROBIO (AP) in a dehydroepiandrosterone-induced PCOS rat model, revealing significant improvements in reproductive and metabolic parameters through modulation of gut microbiota and enhancement of arginine biosynthesis.
-
NewsHPV vaccination provides “sustained protection” against cervical cancer
Human papillomavirus (HPV) vaccination is associated with a significantly reduced risk of invasive cervical cancer, with no indication of waning protection up to 18 years after vaccination, finds a study.
-
NewsMeningococcal B vaccination does not reduce gonorrhoea, trial results show
Contrary to existing evidence from observational studies, the meningococcal B vaccine (4CMenB) has no effect on preventing the acquisition of gonorrhoea, according to the results of the world’s largest randomised control trial (RCT) into possible efficacy.
-
NewsNeonatal sepsis: using vaginal microbiota to improve predictions
Researchers have found that some identifiable microbial signatures in vaginal swab samples taken at delivery are associated with a risk of neonatal sepsis.
-
NewsResearchers discover that vaginal bacteria don’t always behave the same way
By analyzing vaginal microbiome data at unprecedented resolution, researchers have identified 25 distinct vaginal microbiome types and demonstrated that bacteria of the same species can differ substantially in their functional potential, thereby affecting how these microbes interact with the body.
-
NewsTesting menstrual blood for HPV could be “robust alternative” to cervical screening
Testing menstrual blood for human papillomavirus (HPV) could be a “robust alternative or replacement” for current cervical cancer screening by a clinician, finds a study. The researchers say using menstrual blood for HPV testing is convenient and non-invasive.
-
NewsAncient DNA pushes back record of treponemal disease-causing bacteria by 3,000 years
Scientists have recovered a genome of Treponema pallidum from 5,500-year-old human remains in Sabana de Bogotá, Colombia. The research expands knowledge about the history of this infectious disease and its occurrence in human populations.
-
NewsA testing paradox for sexually transmitted infections
Surveillance evidence shows an increase in people infected with other STIs after initiating PrEP. A new study provides a counterintuitive explanation revealing a testing paradox: even when the observed cases increase, the true numbers of STIs can decrease.
-
NewsBiomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).
-
NewsImaging reveals bacterial symbionts in the ovaries of tiny, aquatic crustaceans
Researchers have imaged a heritable form of bacterial symbiosis inside the reproductive system of tiny crustaceans known as ostracods. Bacteria from the genus Cardinium live inside the egg cells and tissues of ostracod ovaries, transmitted from mothers to offspring.
-
NewsStudent’s unexpected rise as a researcher leads to critical new insights into HPV
In two years, a student went from lab novice to medical diagnostics honors student whose study revealed how mutations in HPV proteins may increase cancer risk.
-
NewsStudy shows HPV vaccine protects vaccinated — and unvaccinated — women
A study has found that the introduction of the human papillomavirus (HPV) vaccine in community settings is highly effective in protecting young women from infections caused by the cervical-cancer-causing virus—including women who didn’t even receive the vaccine.
-
NewsGut infections often overlooked in men who have sex with men
It’s time to develop more effective ways to control and prevent sexually transmitted gut infections, urge the authors of an article that discusses discuss several sexually transmitted enteric pathogens that have become extremely multi-drug resistant.
-
NewsU.S. Public Health Service releases new guidelines on occupational HIV exposure and postexposure prophylaxis
The CDC, on behalf of the U.S. Public Health Service (PHS), has released the 2025 Guidelines for the Management of Occupational Exposure to Human Immunodeficiency Virus (HIV) and Recommendations for Postexposure Prophylaxis (PEP).
-
NewsWorld-first koala chlamydia vaccine approved
In a world first, a vaccine has been approved to protect Australia’s endangered koalas from infection and death caused by chlamydia.
-
NewsOne dose of antibiotic treats early syphilis as well as three doses
Researchers have found that a single injection of the antibiotic benzathine penicillin G (BPG) successfully treated early syphilis just as well as the three-injection regimen used by many clinicians. These findings from a late-stage clinical trial suggest the second and third doses of conventional BPG therapy do not provide a health benefit.